Naproxen-induced nephropathy in systemic lupus erythematosus.
A 34-year-old female with an 8-month history of systemic lupus erythematosus and intermittent naproxen use presented with acute oliguric renal failure, hypoalbuminemia, 4+ proteinuria, and an active urinary sediment. The clinical picture suggested a rapidly progressive lupus glomerulonephritis. Renal biopsy, however, demonstrated chronic, active interstitial nephritis without evidence of immune deposits by immunofluorescence or electron microscopy. Nonsclerotic glomeruli revealed diffuse foot process fusion without cellular proliferation. These findings were consistent with nonsteroidal anti-inflammatory drug induced nephropathy. Discontinuation of naproxen and institution of corticosteroid therapy was followed by improvement in renal function and remission of nephrotic syndrome. This case represents the first report of nonsteroidal antiinflammatory drug nephropathy associated with systemic lupus erythematosus.
Ling
B N
BN
Department of Medicine, Emory University School of Medicine, Atlanta, Ga.
Bourke
E
E
Campbell
W G
WG
Delaney
V B
VB
D058186:Acute Kidney Injury / Q000139:chemically induced; D000328:Adult; D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000139:chemically induced / Q000473:pathology; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D009288:Naproxen / Q000009:adverse effects*; D009395:Nephritis, Interstitial / Q000139:chemically induced / Q000473:pathology; D009404:Nephrotic Syndrome / Q000139:chemically induced; D011507:Proteinuria / Q000139:chemically induced
D009288:Naproxen